Psychemedics Stock Current Valuation
| PMD Stock | USD 2.55 0.09 3.41% |
Valuation analysis of Psychemedics helps investors to measure Psychemedics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value is expected to grow to about 44.4 M, whereas Enterprise Value Over EBITDA is projected to grow to (65.57). Fundamental drivers impacting Psychemedics' valuation include:
Price Book 2.3968 | Enterprise Value 15.6 M | Enterprise Value Ebitda (65.04) | Price Sales 0.7237 | Enterprise Value Revenue 0.7388 |
Undervalued
Today
Please note that Psychemedics' price fluctuation is moderately volatile at this time. Calculation of the real value of Psychemedics is based on 3 months time horizon. Increasing Psychemedics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Psychemedics is useful when determining the fair value of the Psychemedics stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Psychemedics. Since Psychemedics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Psychemedics Stock. However, Psychemedics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.55 | Real 2.71 | Hype 2.58 | Naive 2.67 |
The real value of Psychemedics Stock, also known as its intrinsic value, is the underlying worth of Psychemedics Company, which is reflected in its stock price. It is based on Psychemedics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Psychemedics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Psychemedics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Psychemedics helps investors to forecast how Psychemedics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Psychemedics more accurately as focusing exclusively on Psychemedics' fundamentals will not take into account other important factors: Psychemedics Company Current Valuation Analysis
Psychemedics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Psychemedics Current Valuation | 15.64 M |
Most of Psychemedics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Psychemedics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Psychemedics Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Psychemedics is extremely important. It helps to project a fair market value of Psychemedics Stock properly, considering its historical fundamentals such as Current Valuation. Since Psychemedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Psychemedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Psychemedics' interrelated accounts and indicators.
Click cells to compare fundamentals
Psychemedics Current Valuation Historical Pattern
Today, most investors in Psychemedics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Psychemedics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Psychemedics current valuation as a starting point in their analysis.
Psychemedics Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Psychemedics has a Current Valuation of 15.64 M. This is 99.89% lower than that of the Health Care Providers & Services sector and 99.8% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.91% higher than that of the company.
Psychemedics Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Psychemedics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Psychemedics could also be used in its relative valuation, which is a method of valuing Psychemedics by comparing valuation metrics of similar companies.Psychemedics is currently under evaluation in current valuation category among related companies.
Psychemedics Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.17) % | ||||
| Current Valuation | 15.64 M | ||||
| Shares Outstanding | 5.81 M | ||||
| Shares Owned By Insiders | 22.70 % | ||||
| Shares Owned By Institutions | 22.30 % | ||||
| Number Of Shares Shorted | 16.88 K | ||||
| Price To Earning | 92.08 X | ||||
| Price To Book | 2.40 X | ||||
| Price To Sales | 0.72 X | ||||
| Revenue | 22.1 M | ||||
| Gross Profit | 9.29 M | ||||
| EBITDA | (251 K) | ||||
| Net Income | (4.15 M) | ||||
| Cash And Equivalents | 1.79 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 2.3 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 2.06 X | ||||
| Book Value Per Share | 1.15 X | ||||
| Cash Flow From Operations | (1.48 M) | ||||
| Short Ratio | 1.79 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 32.0 | ||||
| Number Of Employees | 116 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 15.31 M | ||||
| Total Asset | 13.27 M | ||||
| Retained Earnings | (16.77 M) | ||||
| Working Capital | 2.1 M | ||||
| Current Asset | 8.46 M | ||||
| Current Liabilities | 3.56 M | ||||
| Annual Yield | 0.11 % | ||||
| Five Year Return | 5.18 % | ||||
| Net Asset | 13.27 M | ||||
| Last Dividend Paid | 0.07 |
About Psychemedics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Psychemedics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Psychemedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Psychemedics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Psychemedics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Psychemedics' short interest history, or implied volatility extrapolated from Psychemedics options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Psychemedics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Psychemedics Piotroski F Score and Psychemedics Altman Z Score analysis. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Psychemedics Stock analysis
When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 0.07 | Earnings Share (0.72) | Revenue Per Share 3.85 | Quarterly Revenue Growth (0.12) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.